Vivani Medical completes dosing of all SLIM-1 trial participants
Vivani Medical, Inc. (Nasdaq: VANI) announced the completion of initial dosing for all 20 participants in its SLIM-1 Phase 1 ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
